Tango Therapeutics (TNGX) Return on Sales (2020 - 2025)
Historic Return on Sales for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to 0.3%.
- Tango Therapeutics' Return on Sales rose 28100.0% to 0.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.51%, marking a year-over-year increase of 13300.0%. This contributed to the annual value of 3.1% for FY2024, which is 3100.0% down from last year.
- Latest data reveals that Tango Therapeutics reported Return on Sales of 0.3% as of Q3 2025, which was up 28100.0% from 12.21% recorded in Q2 2025.
- Over the past 5 years, Tango Therapeutics' Return on Sales peaked at 0.3% during Q3 2025, and registered a low of 12.21% during Q2 2025.
- For the 5-year period, Tango Therapeutics' Return on Sales averaged around 4.13%, with its median value being 4.2% (2022).
- As far as peak fluctuations go, Tango Therapeutics' Return on Sales surged by 28900bps in 2023, and later plummeted by -109300bps in 2025.
- Tango Therapeutics' Return on Sales (Quarter) stood at 3.86% in 2021, then dropped by -18bps to 4.54% in 2022, then fell by -25bps to 5.66% in 2023, then plummeted by -61bps to 9.14% in 2024, then skyrocketed by 103bps to 0.3% in 2025.
- Its Return on Sales stands at 0.3% for Q3 2025, versus 12.21% for Q2 2025 and 7.4% for Q1 2025.